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Background: A mastoid cavity resulting from a canal wall down mastoidectomy can result in major morbidity for
patients due to chronic otorrhea and infection, difficulty with hearing aids and vertigo with temperature changes.
Mastoid obliteration with reconstruction of the bony external ear canal recreates the normal anatomy to avoid such
morbidity. Few have the studied the quality of life benefit that this procedure confers.
Methods: This retrospective observational study was conducted to determine if mastoid obliteration with
autologous cranial bone graft following mastoidectomy improves quality of life (QOL). Patients with cholesteatoma
who had mastoidectomy with primary or secondary mastoid obliteration by a tertiary otologist were surveyed
using the validated Glasgow Benefit Inventory (GBI), our primary outcome measure.
Results: Fifty-eight patients were interviewed. Forty-six were primary obliteration after canal wall down
mastoidectomy of a primary cholesteatoma. Twelve were secondary obliteration of an existing canal wall down
mastoid cavity. Overall GBI scores were improved, with average scores of 22. Average general subscale scores were
23, physical health scores were 25, and social health scores were 22. The primary obliteration group had average
scores of 19, general subscale scores of 20, physical health scores of 21, and social health scores of 22. Those with
secondary obliteration scored higher, with average scores of 31, general subscale scores of 34, physical health
scores of 39, and social health scores of 25.
Conclusion: This study shows that mastoidectomy with obliteration using autologous cranial bone graft offers a
significant QOL benefit. The GBI scores compare favourably with other otorhinolaryngology procedures. Secondary
obliterations after revision mastoidectomy scored much higher than primary obliterations. This is currently the only
QOL study comparing these two patient groups.
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Glasgow benefit inventoryBackground
A canal wall-down mastoid cavity constitutes a major
morbidity to patients with chronic ear disease. The con-
sequences include susceptibility to infection with any
water exposure, recurrent otorrhea, the need for fre-
quent cleaning, difficulty with the use of conventional
hearing aids and vertigo caused by warm or cold air or
water exposure [1].
Mastoid obliteration with reconstruction of the bony
external ear canal [2] is a procedure that is used to avoid
all these complications. In 1911, Mosher introduced the* Correspondence: admin@edmontonearclinic.com
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reproduction in any medium, provided the orconcept of mastoid obliteration [3]. Since then various
techniques and graft material have been described. Local
fascial musculo-periosteal flaps, autologous grafts such
as bone, cartilage and ceramic materials such as hy-
droxyapatite have been used [2,4-7].
Palva [8] introduced the use of bone chips and bone
pate in combination with a musculo-periosteal flap to
obliterate the mastoid cavity [8]. This has been re-
commended as a primary procedure at the time of canal
wall down mastoidectomy. However, for a problematic
non-healing mastoid cavity with chronic otorrhea, a se-
condary or revision procedure could be done.
Very few studies have been published regarding the
quality of life (QOL) change due to primary or secondaryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pact of the secondary mastoid obliteration on QOL using
the Glasgow Benefit Inventory (GBI). The majority of their
patients reported improved QOL and control of the
otorrhea afterwards. However, to date, no comparison has
been done on the impact on QOL between primary mas-
toid obliteration and secondary obliteration.
The GBI was first developed by Robinson at al. [10] to
measure the change in health status due to an inter-
vention. It is a validated, retrospective, single adminis-
tration test which captures change in health status
brought about by a specific event. The questionnaire
was designed as an adult otorhinolaryngology (ORL) sur-
vey but has been used in other specialties [11,12] and
also in the pediatric age group [13,14].
In otolaryngology, the GBI showed improvement in
quality of life after different procedures such as intra-
tympanic dexamethasone [15] and intratympanic gen-
tamicin for Meniere’s Disease [16], rhinoplasty [17],
endoscopic dacryocystorhinostomy (DCR) [12], and ton-
sillectomy [18,19]. It also showed minimal improvement
of overall health-related quality of life after septoplasty
[20]. In otology and neurotology, it has been used to as-
sess QOL in acoustic neuroma patients following micro-
surgery [21], after bone anchored hearing aids [13,14,22]
and after stapes surgery [23].
The aim of this study is to describe the change in
health status in patients after mastoidectomy and mas-
toid obliteration. It also looks at the change in QOL
between mastoidectomy with primary mastoid oblite-
ration and secondary obliteration.
Methods
Patient selection
This is a retrospective QOL study. Ethics approval was
obtained at University of Alberta Research Ethics Office
(Pro00026634). Seventy-two patients who had under-
gone canal wall down mastoidectomy with mastoid
obliteration using autologous cranial bone graft from
2009 till 2012 were identified as possible candidates.
Patients with primary cholesteatoma who had mastoid-
ectomy and mastoid obliteration were defined as having
primary obliteration. Secondary obliterations were those
with an existing canal wall down mastoidectomy who
were having otorrhoea and who had revision mastoi-
dectomy and mastoid obliteration. All patients were
operated on by one tertiary otologist, therefore standar-
dizing technique.
Twenty-four patients who had primary obliteration
were contacted over the phone by the interviewer who
went through the GBI with these patients. Forty-eight
patients were identified as requiring an interview in per-
son during their clinic visit. This group consisted of
those who had secondary obliterations, multiple earsurgeries, and patients who had primary surgery but
had a language barrier that hindered communication
over the phone. Two patients out of this last group were
excluded from the study due to non-compliance with
postoperative treatment and follow up. In addition, one
patient just had surgery recently and it was too soon to
interview him. Another 12 could not be contacted either
because they were out of country or had changed
addresses. Ultimately, only 34 of these 48 patients com-
pleted a GBI in clinic with the help of an interviewer.
58 of the 72 patients, 81% of the originally identified
patients, completed their GBI questionnaires.
Surgical technique
In the primary procedure, a post-auricular incision was
performed. A U-shaped superiorly pedicled temporalis
muscle flap was raised off the mastoid bone consisting of
temporalis muscle, temporalis fascia and some peri-
cranium. The temporalis muscle was dissected from the
underlying mastoid bone from the mastoid tip superiorly
to the temporal line. The muscle was then retracted su-
periorly to expose 1 to 2 cm of the pericranium above the
temporal line. Bone chips were harvested with a large
chisel and mallet from the healthy, disease-free cortex of
the mastoid bone before the mastoidectomy was
performed so that the cranial autologous bone graft was
not contaminated by disease. The bone chips were laid in
cool normal saline to keep fresh. Bone pate was then col-
lected in a special bone dust collector from the lateral
mastoid cortex and laid to dry. The mastoidectomy was
begun after harvesting the bone graft. At the end of the
canal wall down mastoidectomy, the bone chips were used
to obliterate the mastoid cavity and the epitympanum.
The bone pate was used to resurface and reconstruct the
external ear canal. Temporalis fascia was used to provide
soft tissue cover over the bone graft onto which the
remaining skin flaps of the ear canal were placed.
In the secondary procedure the only difference was
that the pre-existing mastoid cavity was already present
before the harvesting of the bone graft. Again, like the
primary procedure the autologous cranial bone graft, in
the form of bone chips and bone pate were harvested in
the same way prior to breaking into the mastoid cavity.
All the skin lining the mastoid cavity was removed so as
to not risk burying a cholesteatoma during the mastoid
obliteration. After the completion of the revision mas-
toidectomy, the task of obliterating the mastoid cavity
with bone chips and resurfacing the bony external ear
canal with bone pate progressed in just the same way as
the primary procedure.
Outcome measure
QOL of our 58 patients were measured using the
Glasgow Benefit Inventory (GBI) survey described by
Figure 1 GBI questionnaire.
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survey consists of 18 questions. Of the eighteen GBI
questions, twelve correspond to general improvement of
QOL, three to social improvement, and three to physical
improvement. Each question asks the patient to indicate
their response on a Likert one to five scale. It was
chosen as our main outcome measure because it is a
validated post-intervention change in QOL question-
naire that does not require pre-intervention administra-
tion of the questionnaire. This was the ideal tool for our
retrospective QOL study. As it has been used widely to
survey QOL change of several otorhinolaryngology
procedures, we would also be able to assess how this
specific surgical procedure ranks with other otolaryn-
gology procedures. GBI scores were calculated as per
Robinson [10]. Each calculated domain had a scale
from −100 to +100 with zero being no change from the
intervention, -100 being maximal deterioration and +100
being maximum QOL improvement.
A chart review was done to obtain demographic and
additional information such as the duration of symptoms
before the obliteration was attempted, date of surgery,
and whether the patient had other middle ear surgeries.
Statistical analysis was performed using SPSS.
Results
Patient demographics
Fifty-eight patients were interviewed in person or via
telephone from October 2012 to January 2013. Average
patient age was forty years (Range 11–80, SD 16), and
thirty-one patients were male. Twenty-eight right ears
(48%) were operated on. Forty-six were primary cases
(79%), while twelve (21%) were secondary, with average
time to obliteration of existing cavity being 2.9 years
(Range 0–42, SD 8.5) (Table 1).
Complications
Postoperative complications included five temporalis
fascia graft infections that eventually achieved full epi-
thelialization. Infection delayed full healing by appro-
ximately three weeks. There were also two ear canal
irregularities requiring minor canalplasties, and one tym-
panic membrane perforation that eventually healed. Re-







Average age (std dev) in years 40 (16) 43 (16) 30 (14)
Male 31 24 7
Female 27 22 5
Right ears 28 24 4
Left ears 30 22 8patients (6.8%), with three recurrences in the epitym-
panum and one in the oval window region. Recurrence
was never in the obliterated mastoid cavity and no cases
required the mastoid obliteration to be taken down.
GBI scores
Evaluating our entire cohort of 58 patients, overall GBI
scores were improved, with average overall scores of +22.
The subgroup with primary obliteration had an average
total GBI score of +19. Primary canal wall down mastoid-
ectomy with mastoid obliteration with autologous cranial
bone graft confers improvement in QOL. The subgroup
with secondary obliteration of an existing cavity had an
average total GBI score of +31. Comparing the primary
and secondary obliteration subgroups, the difference in
overall GBI score was not statistically significant (Mann
Whitney U test p = 0.14). A summary of the raw GBI
questionnaire data is provided in Table 2.
After primary obliteration, 33 of 46 (72%) reported im-
proved QOL compared to 10 of 12 (83%) after secondary
obliteration. With regard to the general, physical, and
social subscales, while both primary and secondary obli-
teration patients reported an improved quality of life,
those with secondary obliteration reported a more dra-
matic change in quality of life. Revision canal wall down
mastoidectomy with secondary mastoid obliteration to re-
construct the bony external ear canal with autologous cra-
nial bone graft confers great improvement of QOL. A
comparison between subgroups is summarized in Table 3.
The general subscale scores was +23 for the entire cohort
of 58 patients, +20 for the primary obliteration group
(n = 47) and +34 in the secondary obliteration group
(n = 12). This difference was not statistically significant
(Mann Whitney U test p = 0.10). As for the physical health
subscale scores, our entire cohort scored +25 whilst the
primary obliteration group scored +21 and the secondary
obliteration group score +39. This difference was not sta-
tistically significant (Mann Whitney U test p = 0.15). Our
entire cohort and primary obliteration group scored +22
for social support. The secondary obliteration group
scored +25. This difference was not statistically significant
(Mann Whitney U test p = 0.43).
For the entire cohort, the most positive changes in
health status were seen in change in overall effect on
life (Question 2), their optimism about the future
(Question 3), feeling better about themselves (Question
14), and in the things that the patient did (Question 1).
For the primary obliteration group, the most positive
effects were reflected in the answers from the same
four questions. For the secondary obliteration group,
the most positive changes in health status were seen in
things that the patient did (Question 1), their optimism
about the future (Question 3), feeling better about
themselves (Question 14), being less inconvenienced by
Table 2 GBI summary of results
Question Median Interquartile
range
Number of respondents per answer
5 4 3 2 1
1. Effect on life 4 2 21 12 15 8 2
2. Overall effect on life 4 2 22 19 12 3 2
3. Optimism about future 4 2 17 23 14 3 1
4. Embarrassment 3 1 11 13 29 3 2
5. Self-confidence 3.5 1 9 20 27 1 1
6. Dealing with company 3 1 7 16 26 7 2
7. Support from friends 3 1 4 24 30 0 0
8. Visits to GP 3 1 8 16 32 1 1
9. Job opportunities 3 1 7 15 30 6 0
10. Self- consciousness 3 1 9 7 36 6 0
11. People who care 3 0 4 6 48 0 0
12. Frequency of illness 3 1 10 11 33 4 0
13. Frequency of medication 3 1 12 10 33 3 0
14. Self-opinion 4 2 16 20 17 4 1
15. Family support 3 1 8 16 34 0 0
16. Inconvenience 4 1.25 14 18 16 8 3
17. Social activities 3 1 6 13 36 3 0
18. Social situations 3 1 4 11 37 5 1
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Discussion
This study is the first study reporting significant improve-
ment in QOL with mastoidectomy, mastoid obliteration
and external ear canal reconstruction using autologous
cranial bone graft in a Canadian population.
The GBI captured just a few QOL factors that expe-
rienced most change in health status for our cohort of
patients. Questions regarding change in what things
patients did, overall effect on life, optimism about the























22 22 25 0.43significant positive improvements by our entire cohort. In
the secondary obliteration group positive change in self-
confidence and being less inconvenienced by their ears
were also reported as significant changes. Dornhoffer et al.
[9] also reports positive changes in effect on life, self-
confidence and being less inconvenienced. Being less
self-conscious, less embarrassed and improvement in so-
cial situations were also reported by his patients but these
were not found to be as significant in our patients.
Our GBI results compare favourably with the GBI
scores for general otorhinolaryngology procedures such
as tonsillectomy +19 [19], septoplasty +11 [20], rhino-
plasty +20 [17], endoscopic sinus surgery +23 [24] and
endoscopic DCR +32 [12].
Our GBI scores are consistent with the current litera-
ture reporting improved health status after surgery in pa-
tients suffering from chronic otitis media. Robinson et al.
[10] reported that the total GBI score for patients who ex-
perience no discharge after chronic ear surgery was +17.
Of their cases 122 had mastoid surgery and 16 had
myringoplasty for otorrhoea. Bergin [25] used the GBI to
evaluate the impact of different otology procedures. He
found that tympano-mastoidectomy had a mean total GBI
score of 3.8, mean general GBI score of 2.0. Patients who
had ossiculoplasty and tympano-mastoidectomy in his
study had a mean total GBI score of 14.2, mean general
GBI score of 18.5. His analyses of revision mastoidectomy
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score of 22.5. Dornhoffer et al. [9] reported a mean total
GBI score of +28.9 for their 23 patients who had revision
mastoidectomy and secondary obliteration of their mas-
toid cavity using demineralised bone matrix and autolo-
gous auricular cartilage. Our cohort of secondary mastoid
obliteration with autologous bone graft scored +31.
The GBI scores of our patients were similar to other
otology procedures such as ossicular manipulation +16.6
[25], stapedectomy +23.3 [25], stapedotomy +29 [23],
intratympanic gentamicin for Meniere’s disease +30 [16]
and intratympanic dexamthasone for Meniere’s + 30 [15].
Studies on BAHA +34 [13], ossiculoplasty +34 [10] and
cochlear implantation +40 [10] reported higher total GBI
scores.
To date, our study is the first and largest study using a
validated change in QOL tool to compare the change in
QOL between primary and secondary mastoid obliteration
with autologous cranial bone graft. One recent study com-
paring change in health status between primary and revi-
sion mastoidectomy groups [26] reported improvement in
QOL in both groups 1 year after surgery. Their patients
had a combination of canal wall up mastoidectomy or
canal wall down mastoidectomy without mastoid obli-
teration. They reported that improvement in QOL was
greater in the primary surgery group compared with the
group who had revision mastoidectomy. Contrary to their
results, our experience was that the change in QOL is
more readily apparent in the patients who had secondary
obliteration as opposed to primary obliteration group.
This stands to reason, as the patients who had secondary
obliteration without mastoid obliteration had significant
“mastoid misery” and otorrhea with their canal wall down
mastoid cavities. We believe that the GBI captured the
true change in QOL with this group and also demon-
strated the lesser clinical change in QOL in the group
who had primary mastoid obliteration at the time of their
first canal wall down mastoidectomy. However, this clini-
cally noted difference was not statistically significant using
the Mann–Whitney analysis when the level of significance
was set at p < 0.05. The smaller number of patients in the
secondary group compared with the larger primary group
may be the reason for this result. We therefore suggest
that further prospective study on a larger group of patients
who have had secondary mastoid obliteration using this
technique would be a useful addition to the current
literature.
Conclusion
Mastoidectomy with obliteration using autologous bone
graft is one of the treatment options for patients with
chronic otitis media. Mastoidectomy with obliteration pro-
vides a quality of life benefit to patients, and this appears to
be more pronounced in those with secondary obliteration.Competing interests
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